{"id":"https://openalex.org/W2995159803","doi":"https://doi.org/10.1080/13543784.2020.1708324","title":"Investigational drugs in phase II clinical trials for acute coronary syndromes","display_name":"Investigational drugs in phase II clinical trials for acute coronary syndromes","publication_year":2019,"publication_date":"2019-12-23","ids":{"openalex":"https://openalex.org/W2995159803","doi":"https://doi.org/10.1080/13543784.2020.1708324","mag":"2995159803","pmid":"https://pubmed.ncbi.nlm.nih.gov/31869253"},"language":"en","primary_location":{"id":"doi:10.1080/13543784.2020.1708324","doi":"https://doi.org/10.1080/13543784.2020.1708324","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1708324","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020726566","display_name":"Amit Rout","orcid":"https://orcid.org/0000-0002-0911-240X","observed_orcids":["https://orcid.org/0000-0002-0911-240X"]},"institutions":[{"id":"https://openalex.org/I2800667924","display_name":"Sinai Hospital","ror":"https://ror.org/052ra0j05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]},{"id":"https://openalex.org/I4210164053","display_name":"LifeBridge Health","ror":"https://ror.org/05g35d951","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164053"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit Rout","raw_affiliation_strings":["Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA","institution_ids":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074051117","display_name":"Ajaypaul Sukhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800667924","display_name":"Sinai Hospital","ror":"https://ror.org/052ra0j05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]},{"id":"https://openalex.org/I4210164053","display_name":"LifeBridge Health","ror":"https://ror.org/05g35d951","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164053"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajaypaul Sukhi","raw_affiliation_strings":["Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA","institution_ids":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041799937","display_name":"Rahul Chaudhary","orcid":"https://orcid.org/0000-0002-3276-385X","observed_orcids":["https://orcid.org/0000-0002-3276-385X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rahul Chaudhary","raw_affiliation_strings":["Division of Hospital Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hospital Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105782782","display_name":"Kevin P. Bliden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800667924","display_name":"Sinai Hospital","ror":"https://ror.org/052ra0j05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]},{"id":"https://openalex.org/I4210164053","display_name":"LifeBridge Health","ror":"https://ror.org/05g35d951","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164053"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin P Bliden","raw_affiliation_strings":["Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA","institution_ids":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011626347","display_name":"Udaya S. Tantry","orcid":"https://orcid.org/0000-0002-8542-8596","observed_orcids":["https://orcid.org/0000-0002-8542-8596"]},"institutions":[{"id":"https://openalex.org/I2800667924","display_name":"Sinai Hospital","ror":"https://ror.org/052ra0j05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]},{"id":"https://openalex.org/I4210164053","display_name":"LifeBridge Health","ror":"https://ror.org/05g35d951","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164053"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Udaya S Tantry","raw_affiliation_strings":["Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA","institution_ids":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012918602","display_name":"Paul Alfred Gurbel","orcid":"https://orcid.org/0000-0002-5461-568X","observed_orcids":["https://orcid.org/0000-0002-5461-568X"]},"institutions":[{"id":"https://openalex.org/I2800667924","display_name":"Sinai Hospital","ror":"https://ror.org/052ra0j05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]},{"id":"https://openalex.org/I4210164053","display_name":"LifeBridge Health","ror":"https://ror.org/05g35d951","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164053"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul A Gurbel","raw_affiliation_strings":["Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, LifeBridgehealth, Baltimore, MD, USA","institution_ids":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5012918602"],"corresponding_institution_ids":["https://openalex.org/I2800667924","https://openalex.org/I4210164053"],"apc_list":null,"apc_paid":null,"fwci":0.2228,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.24820599,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"29","issue":"1","first_page":"33","last_page":"47"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.012299999594688416,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8769999742507935},{"id":"https://openalex.org/keywords/novel-therapeutic-agents","display_name":"novel therapeutic agents","score":0.6200000047683716},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.9300000071525574},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.7549999952316284},{"id":"https://openalex.org/keywords/anakinra","display_name":"anakinra","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":1.0},{"id":"https://openalex.org/keywords/csl112","display_name":"CSL112","score":0.9819999933242798},{"id":"https://openalex.org/keywords/inclisiran","display_name":"inclisiran","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rvx-208","display_name":"RVX-208","score":0.9710000157356262},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8598515391349792},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6845542192459106},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6617113351821899},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.6407537460327148},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.5733156800270081},{"id":"https://openalex.org/C2781228260","wikidata":"https://www.wikidata.org/wiki/Q415411","display_name":"Anakinra","level":3,"score":0.4971816837787628},{"id":"https://openalex.org/C2910824759","wikidata":"https://www.wikidata.org/wiki/Q6060674","display_name":"Investigational Drugs","level":3,"score":0.4723176658153534},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.43100103735923767},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38254278898239136},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1959071159362793},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.17924222350120544},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08584430813789368}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/13543784.2020.1708324","doi":"https://doi.org/10.1080/13543784.2020.1708324","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1708324","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:31869253","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31869253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":98,"referenced_works":["https://openalex.org/W16807914","https://openalex.org/W120386687","https://openalex.org/W1011071646","https://openalex.org/W1512569924","https://openalex.org/W1547437950","https://openalex.org/W1805934449","https://openalex.org/W1981377319","https://openalex.org/W1988456139","https://openalex.org/W1989197319","https://openalex.org/W1989454102","https://openalex.org/W1991883893","https://openalex.org/W1995253472","https://openalex.org/W1996953412","https://openalex.org/W2000857749","https://openalex.org/W2001314633","https://openalex.org/W2006653167","https://openalex.org/W2022798793","https://openalex.org/W2027132059","https://openalex.org/W2028421152","https://openalex.org/W2032049229","https://openalex.org/W2039351074","https://openalex.org/W2044341624","https://openalex.org/W2048836565","https://openalex.org/W2049022217","https://openalex.org/W2051015522","https://openalex.org/W2065907781","https://openalex.org/W2069242363","https://openalex.org/W2074130375","https://openalex.org/W2075188927","https://openalex.org/W2092669657","https://openalex.org/W2094875652","https://openalex.org/W2095507444","https://openalex.org/W2106107076","https://openalex.org/W2110083155","https://openalex.org/W2110296547","https://openalex.org/W2119301730","https://openalex.org/W2123179625","https://openalex.org/W2126147349","https://openalex.org/W2138746166","https://openalex.org/W2143049896","https://openalex.org/W2144663588","https://openalex.org/W2145189353","https://openalex.org/W2146258814","https://openalex.org/W2148658155","https://openalex.org/W2151223394","https://openalex.org/W2161939173","https://openalex.org/W2165275387","https://openalex.org/W2170723975","https://openalex.org/W2176701303","https://openalex.org/W2182204189","https://openalex.org/W2204048255","https://openalex.org/W2234034631","https://openalex.org/W2239911561","https://openalex.org/W2279294247","https://openalex.org/W2305945749","https://openalex.org/W2337488815","https://openalex.org/W2338475291","https://openalex.org/W2347011549","https://openalex.org/W2402119165","https://openalex.org/W2407715104","https://openalex.org/W2484337260","https://openalex.org/W2530905492","https://openalex.org/W2549082007","https://openalex.org/W2555483953","https://openalex.org/W2558563547","https://openalex.org/W2593823350","https://openalex.org/W2595169180","https://openalex.org/W2604069439","https://openalex.org/W2606642103","https://openalex.org/W2607464901","https://openalex.org/W2620405441","https://openalex.org/W2621349830","https://openalex.org/W2626246102","https://openalex.org/W2746702622","https://openalex.org/W2747698110","https://openalex.org/W2748400555","https://openalex.org/W2764311960","https://openalex.org/W2765544638","https://openalex.org/W2783921920","https://openalex.org/W2791101683","https://openalex.org/W2792059319","https://openalex.org/W2793477763","https://openalex.org/W2795303754","https://openalex.org/W2809523332","https://openalex.org/W2848978533","https://openalex.org/W2883597367","https://openalex.org/W2884358464","https://openalex.org/W2884800433","https://openalex.org/W2891588973","https://openalex.org/W2899069234","https://openalex.org/W2899669642","https://openalex.org/W2899885364","https://openalex.org/W2900418923","https://openalex.org/W2900803065","https://openalex.org/W2902864343","https://openalex.org/W2943109321","https://openalex.org/W2951807550","https://openalex.org/W2960426719"],"related_works":["https://openalex.org/W4297236433","https://openalex.org/W3040476431","https://openalex.org/W2527543990","https://openalex.org/W2319340518","https://openalex.org/W2940206944","https://openalex.org/W2149361383","https://openalex.org/W2071957250","https://openalex.org/W4394878929","https://openalex.org/W4287010319","https://openalex.org/W2129707460"],"abstract_inverted_index":{"Introduction:":[0],"Despite":[1],"current":[2],"guideline-based,":[3],"secondary":[4],"prevention":[5],"strategies":[6,40],"in":[7,49,85,101,131,154,157],"patients":[8,50],"with":[9,51,63],"the":[10,14,43,57,72,97,102,141],"acute":[11],"coronary":[12],"syndrome,":[13],"residual":[15],"ischemic":[16],"risk":[17],"is":[18,26],"still":[19],"at":[20],"an":[21],"unacceptable":[22],"rate,":[23],"and":[24,79,88,122,126],"there":[25],"a":[27,145],"concomitant":[28],"high":[29],"bleeding":[30],"event":[31],"rate.":[32],"These":[33],"observations":[34],"mandate":[35],"investigations":[36,91],"of":[37,74,96,140,151],"novel":[38,98,152],"treatment":[39,73],"to":[41,46],"meet":[42],"unmet":[44],"need":[45],"improve":[47],"outcomes":[48],"ACS.Areas":[52],"covered:":[53],"In":[54],"this":[55],"review,":[56],"author(s)":[58],"focus":[59],"on":[60],"new":[61],"agents":[62,153],"ongoing":[64],"or":[65],"recently":[66],"completed":[67],"phase":[68],"II":[69,83,104],"trials":[70,84,105],"for":[71,81,108,148],"ACS.":[75],"We":[76],"searched":[77],"MEDLINE":[78],"clinicaltrials.org":[80],"Phase":[82,103,134],"ACS":[86],"patients,":[87],"important":[89],"original":[90],"are":[92],"reviewed.Expert":[93],"opinion:":[94],"Some":[95],"drugs":[99],"evaluated":[100,130],"hold":[106],"promise":[107],"future":[109],"therapies":[110],"such":[111],"as":[112],"AZD5718,":[113],"anakinra,":[114],"tocilizumab,":[115],"CSL112,":[116],"MEDI":[117],"6102,":[118],"inclisiran,":[119],"PZ128,":[120],"selatogrel,":[121],"RVX-208.":[123],"Their":[124],"efficacy":[125],"safety":[127],"should":[128],"be":[129,144],"large":[132],"scale":[133],"III":[135],"trials.":[136],"The":[137],"higher":[138],"cost":[139],"drug":[142],"will":[143],"major":[146],"limitation":[147],"wide-spread":[149],"use":[150],"general":[155],"practice":[156],"future.":[158]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-12-26T00:00:00"}